TRT's OrthoGold 100 is FDA cleared for activation of connective tissue, and FDA registered for pain reduction and improved blood supply.
miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy - As many current approaches for heart regeneration exert unfavourable side effects, the induction of endogenous repair mechanisms in ischaemic heart disease is of particular interest. Recently, exosomes carrying angiogenic miRNAs have been described to improve heart function. However, it remains challenging to stimulate specific release of reparative exosomes in ischaemic myocardium. In the present study, we sought to test the hypothesis that the physical stimulus of shock wave therapy (SWT) causes the release of exosomes. We aimed to substantiate the pro-angiogenic impact of the released factors, to identify the nature of their cargo, and to test their efficacy in vivo supporting regeneration and recovery after myocardial ischaemia. More..
Stem cells pose risk, offer promise - Providing the therapy involves using an FDA cleared device with “genuine” shock waves, according to Irwin Goldstein, MD, a urologist who practices sexual medicine in San Diego and and is director of the nonprofit Institute for Sexual Medicine (SexualMed.org). “There are a lot of imitation non-shock wave acoustic sound waves that are being scammed and sold to patients who are desperate,” said Dr. Goldstein, who uses a device known as the UroGold 100. “Real shock wave therapy has been shown to activate endogenous stem cells. This specific device is FDA cleared now in the U.S. for increasing blood flow, connective tissue activation, and amelioration of pain, and the FDA has classified this device a non-significant risk (NSR) to humans.” More..
Low Intensity Shock Wave Therapy: Regenerative Therapy for Erectile Dysfunction - (Dr Irwin Goldstein MD) Analogy to blood flow imparting physical forces – shear stress - onto endothelial cell to cause a biochemical response. More..
MTS Medical Newsletter - Robert-Bosch-Str. 18, 78467 Konstanz, Germany - China's market is dominated by radial pressure wave equipment. However, there is a current trend towards focused applications. A new market for MTS is emerging here.
TRT July Newsletter - This past March in Atlanta, TRT attended the 2019 Annual Meeting of The International Society For The Study of Women'sSexual Health (ISSWSH). The stars were obviously aligned for TRT on that weekend. We were introduced to Dr. Irwin Gold-stein and his wife Sue. The Goldstein's are considered the foremost experts in the field of sexual Health.
A randomized, sham-controlled clinical trial using the UroGold100 SoftWave device was IRB Approved on July 2nd 2019.- The study is taking place at the prestigious clinic San Diego Sexual Medicine, with former SMSNA and ISSWSH president Dr Irwin Goldstein as principal investigator. The protocol was written by Sue Goldstein who manages clinical research at SDSM. Enrollment with commence immediately. Other top research centers interested in conducting in a similar study may contact TRT.